65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79723D0188
Awardee
Awarding agency
Task orders
6

Award facts

Opportunity
  • M5Q5OA03R8 Solicitation number
Last date to order 64% complete
IDV ceiling
$11,800,000.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

The General Services Administration issued a Federal Supply Schedule contract to Emergent Devices, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on August 15, 2023, with a ceiling value of $11.8 million and performance through August 14, 2028.

The contract covers Schedule 65 IB, pharmaceuticals, drugs, and hematology-related products, with no set-aside category applied. Place of performance is nationwide; the contractor is based in Plymouth Meeting, Pennsylvania. Emergent Devices, Inc. is a for-profit pharmaceutical manufacturer specializing in naloxone products, particularly NARCAN nasal spray formulations used to reverse opioid overdoses.

Multiple delivery orders have been issued under this schedule contract to various federal agencies. Recent activity includes a $111,801.60 first aid kit delivery order to U.S. Customs and Border Protection (completion September 30, 2025), a $66,870.72 naloxone nasal spray order through the Office of Procurement Operations (completion June 12, 2025), a $162,820.80 delivery order to Customs and Border Protection for 4,320 two-dose cycles of NARCAN nasal spray 4mg (completion September 30, 2024), two Federal Emergency Management Agency orders totaling $34,917.36 for naloxone nasal spray (completions May 31, 2024 and June 1, 2024), and an Immigration and Customs Enforcement delivery order for $19,900.32 in support of National Fentanyl Operations (completion October 15, 2023). All delivery orders carry firm fixed-price structures and carry no set-aside designation.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00012 · FSS $0
Supplemental Agreement for work within scope P00011 · PL 2026 price updates $0
Supplemental Agreement for work within scope P00010 · 65IB: SIN 42-2A - product addition transfer from hikma specialty USA INC. 36F79722D0116 $0
Supplemental Agreement for work within scope P00009 $0
Supplemental Agreement for work within scope P00008 $0
Supplemental Agreement for work within scope P00007 · FSS $0
Supplemental Agreement for work within scope P00006 · PPR $0
Supplemental Agreement for work within scope P00005 · FSS $0
Supplemental Agreement for work within scope P00004 · Deletion $0
Supplemental Agreement for work within scope P00003 · FSS $0
Supplemental Agreement for work within scope P00002 · Product addition modification. $0
Supplemental Agreement for work within scope P00001 · FSS $0
Original award $0
Show all 13

Quick answers

Who was awarded contract 36F79723D0188?

36F79723D0188 was awarded to Emergent Devices, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on August 15, 2023.

How much is contract 36F79723D0188 worth?

36F79723D0188's own ceiling is $11,800,000.

How many orders have been placed under contract 36F79723D0188?

6 orders have been placed under 36F79723D0188, the latest on August 1, 2025.

Who can order from contract 36F79723D0188?

36F79723D0188 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79723D0188 part of a contract vehicle?

Yes. 36F79723D0188 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79723D0188 competed?

The extent of competition for 36F79723D0188 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV